REP PROFILE
REP PROFILE
Stacey Ellis
COMPANY
Astra Merck Inc.
TITLE
Customer group manager
CURRENT HOME
Lawrenceburg, KY
Territory: Louisville, KY
Customers: Gastrointestinologists, cardiologists, primary care physicians and internists.
Significant awards: Ellis won the Medal of Merit award three times. She also won the Pinnacle of Achievement award and the Royal Award.
On training specialists: "I coach and counsel six pharmaceutical specialists and manage half of a territory. I attend field calls with the specialists; I discuss each call with them and ask them to evaluate the success of the visit. I give constructive and positive feedback on each call. I believe in being an active participant."
On mirrored partners: "Having mirrored partners allows a company to give more coverage to their customers. Mirrored partners should discuss any issues and observations that they may have noticed in the physician's office at least once a week. The reps can work together to make sure that they meet the needs of their customers."
On being a team player: "Everyone has different strengths and qualities. Working in a team-oriented environment, reps can share their best practices, selling skills and time management skills and in turn improve their own selling skills. I meet with my territory once a month and with my district once a quarter."
Selling techniques: "I focus on the needs of my customers. I listen to them and probe them for information. I ask them about their patient population and prescription preferences. I don't use a lot of studies. I want the physicians to think of me as their resource."
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.